SEC Form 4 · accession 0000921895-18-003353
Citi Trends Inc · CTRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Duskin
Director
Period of report
Dec 17, 2018
Accepted (ET)
Dec 19, 2018 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001318484
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF3,F1 | Dec 17, 2018 | S | 10,000 | $19.4449 | D | 494,010 | I | By Macellum SPV III, LP |
| Common Stock, $0.01 par valueF4,F1 | Dec 18, 2018 | S | 5,000 | $20.0069 | D | 489,010 | I | By Macellum SPV III, LP |
| Common Stock, $0.01 par valueF2 | holding | — | — | — | 5,009 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents securities of the Issuer owned directly by Macellum SPV III, LP ("Macellum SPV"). Macellum Management, LP ("Macellum Management") serves as the investment manager of Macellum SPV. Macellum Advisors GP, LLC ("Macellum GP") serves as the general partner of Macellum Management and Macellum SPV. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities of the Issuer owned directly by Macellum SPV. Mr. Duskin disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F2Includes 2,397 shares of restricted stock awarded to Mr. Duskin in his capacity as a director of the Issuer, which will vest on June 6, 2019, provided Mr. Duskin is a director of the Issuer at such time.
- F3The price reported is a weighted average price. The reported shares were sold in multiple transactions at prices ranging from $19.17 to $19.51. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 3.
- F4The price reported is a weighted average price. The reported shares were sold in multiple transactions at prices ranging from $19.87 to $20.11. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4.